COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators, Prabhat Jha
doi: https://doi.org/10.1101/2021.03.04.21252540
University of Toronto
Prabhat Jha
University of Toronto

Data Availability
Data available upon request and subject to approval from Unity Health Toronto Ethics Review Board and the Canadian COVID-19 Immunity Task Force.
Posted March 05, 2021.
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators, Prabhat Jha
medRxiv 2021.03.04.21252540; doi: https://doi.org/10.1101/2021.03.04.21252540
Subject Area
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3095)
- Dermatology (261)
- Emergency Medicine (463)
- Epidemiology (13033)
- Forensic Medicine (13)
- Gastroenterology (861)
- Genetic and Genomic Medicine (4855)
- Geriatric Medicine (449)
- Health Economics (751)
- Health Informatics (3062)
- Health Policy (1106)
- Hematology (410)
- HIV/AIDS (960)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (500)
- Neurology (4618)
- Nursing (244)
- Nutrition (688)
- Oncology (2389)
- Ophthalmology (675)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (301)
- Palliative Medicine (87)
- Pathology (515)
- Pediatrics (1242)
- Primary Care Research (522)
- Public and Global Health (7197)
- Radiology and Imaging (1606)
- Respiratory Medicine (943)
- Rheumatology (459)
- Sports Medicine (403)
- Surgery (513)
- Toxicology (65)
- Transplantation (221)
- Urology (189)